Application of A beta1-42 in preparation of preeclampsia treatment medicine or diagnostic kit

The invention relates to the technical field of biomedical engineering, discloses application of an A beta 1-42 inhibitor in preparation of an anti-preeclampsia drug, an A beta 1-42 inhibitor recombinant vector and application of the A beta 1-42 inhibitor recombinant vector in preparation of the ant...

Full description

Saved in:
Bibliographic Details
Main Authors LIU WEI, CHENG KAI, GAO QIAN, CAI LEIMING, NIE ZHIWEN, LI QIAN
Format Patent
LanguageChinese
English
Published 03.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to the technical field of biomedical engineering, discloses application of an A beta 1-42 inhibitor in preparation of an anti-preeclampsia drug, an A beta 1-42 inhibitor recombinant vector and application of the A beta 1-42 inhibitor recombinant vector in preparation of the anti-preeclampsia drug, and further provides application of a reagent for detecting the content of A beta 1-42 in preparation of a preeclampsia diagnostic kit. The invention further provides an anti-eclampsia pharmaceutical composition and a pre-eclampsia diagnosis kit. Based on the research on PE placenta and TM stimulated HTR-8/SVneo cells, the expression of A beta 1-42 in the samples is relatively high. Therefore, the accuracy and sensitivity of the PE can be improved by detecting the level of Abeta1-42, and a better scheme is provided for treatment and management of the PE. 本发明涉及生物医药工程技术领域,Aβ1-42抑制剂在制备抗子痫前期药物中的用途、Aβ1-42抑制剂重组载体及其在制备抗子痫前期药物中的用途,还提供了检测Aβ1-42含量的试剂在制备子痫前期诊断试剂盒中的用途,并进一步提供了抗子痫药物组合物和子痫前期诊断试剂盒。本发明基于对PE胎盘和被
Bibliography:Application Number: CN202310246837